Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

SBIO ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

SBIO Analyst Ratings

Strong Buy
100ConsensusRatings
94Buy5Hold1Sell
Based on the Wall Street analyst consensus for 100 of SBIO’s holdings.

SBIO 12 Month Forecast

$112.14â–²(104.37% Upside)
Based on Wall Street analyst 12-month price targets for 100 of ALPS Medical Breakthroughs ETF’s holdings in the last 3 months. The average price target is $112.14 with a high forecast of $150.84 and a low forecast of $78.03. The average price target represents a 104.37% change from the last price of $54.87.
Highest Price Target$150.84Average Price Target$112.14Lowest Price Target$78.03

SBIO Stocks With Highest Upside Potential

SBIO highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$21.25(941.67% Upside)
Strong Buy$24.00(867.74% Upside)
Strong Buy$10.25(768.64% Upside)
Strong Buy$6.11(677.50% Upside)
Moderate Buy$9.00(653.14% Upside)

SBIO Stocks With Highest Downside Potential

SBIO highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Moderate Sell$3.00(-19.14% Downside)
Hold$19.00(-7.86% Downside)
Moderate Buy$35.50(9.98% Upside)
Hold$21.53(15.65% Upside)
Strong Buy$169.00(20.98% Upside)

SBIO ETF FAQ

What is SBIO’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 100 of SBIO’s holdings, ALPS Medical Breakthroughs ETF’s 12-month average price target is $112.14.
What is SBIO’s upside potential, based on the analysts’ average price target?
SBIO’s average price target of $112.14 represents a 104.37% upside from its last price of $54.87.
Is SBIO a Buy, Sell or Hold?
ALPS Medical Breakthroughs ETF has a consensus rating of Strong Buy, based on the analyst consensus for 100 of SBIO’s holdings: 94 rated Buy, 5 rated Hold and 1 rated Sell.
What is ALPS Medical Breakthroughs ETF’s price target?
The average price target for ALPS Medical Breakthroughs ETF is $112.14, based on Wall Street analyst 12-month price targets for 100 of SBIO’s holdings, issued in the past 3 months. The highest price target is $150.84 and the lowest is $78.03. The average price target represents a 104.37% increase from the last price of $54.87.
What is SBIO’s expense ratio?
SBIO’s expense ratio is 0.50%.
How many holdings does SBIO have?
SBIO holds 102 assets.
How can I buy shares of SBIO?
You can buy shares of SBIO through a brokerage account. Compare brokers on our Best Online Brokers page.